Clinical Evidence
254 results
HDx therapy enabled by Theranova
Comparison of Hemodialysis Using a Medium Cutoff Dialyzer versus Hemodiafiltration: A Controlled Cross-Over Study
HDx therapy enabled by Theranova
Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
HDx therapy enabled by Theranova
Comparison of high flux hemodialyzers with medium cut-off dialyzer on the removal of middle high size uremic toxins
HDx therapy enabled by Theranova
Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic T
HDx therapy enabled by Theranova
Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins
HDx therapy enabled by Theranova
Comparison of Hospitalization Rate in Automatized Peritoneal Dialysis Patients with and Without Remote Management Program in Colombia - Rivera A et al.
HDx therapy enabled by Theranova
Comparison of medium cut-off membrane and postdilution hemodiafiltration on removal of small and middle molecule uremic toxins
HDx therapy enabled by Theranova
Comparison of Solute Removal Properties Between High-Efficient Dialysis Modalities in Low Blood Flow Rate
HDx therapy enabled by Theranova
Comparison of the medium cutoff dialyzer and postdilution hemodiafiltration on the removal of small and middle molecule uremic toxins
HDx therapy enabled by Theranova
Comparison of Utilities Consumption Between Different Modalities of In-Center Haemodialysis
PD
Cost Consequence Analysis of a Remote Monitoring Program to Improve Clinical Practice of Automatized Peritoneal Dialysis in Colombia - Ariza J et al.
HDx therapy enabled by Theranova
Current approaches to middle molecule removal: room for innovation
Vantive is a trademark of Vantive Health LLC or its affiliates.